Showing results (1161-1170 of 1,787) with videos related to
Sort By:
Pageof 179
Hepatology Communications|February 7, 2018
Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver diseaseZobair M Younossi, Maria Stepanova, Nila Rafiq, et al.Hepatology Communications|February 7, 2018
Clinical burden of liver disease from hemochromatosis at an academic medical centerSergio A Sánchez-Luna, Kyle E BrownHepatology Communications|February 7, 2018
Idiosyncratic drug-induced liver injury: A short reviewYo-Ichi Yamashita, Katsunori Imai, Kosuke Mima, et al.Hepatology Communications|February 7, 2018
The emergence of NS5B resistance associated substitution S282T after sofosbuvir-based treatmentEdward J Gane, Sophie Metivier, Ronald Nahass, et al.Hepatology Communications|February 7, 2018
Long-term survival after surveillance and treatment in patients with chronic viral hepatitis and hepatocellular carcinomaMyron J Tong, Alexander A Rosinski, Claiborne T Huynh, et al.Hepatology Communications|February 7, 2018
Remodeling the model for end-stage liver disease for predicting mortality risk in critically ill patients with cirrhosis and acute kidney injuryXiao-Dong Zhou, Qin-Fen Chen, Dan-Qin Sun, et al.Hepatology Communications|February 7, 2018
Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosisYoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, et al.Hepatology Communications|February 7, 2018
Segregated hepatocyte proliferation and metabolic states within the regenerating mouse liverShilpi Minocha, Dominic Villeneuve, Leonor Rib, et al.Hepatology Communications|February 7, 2018
Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on hepatic fibrosisTadashi Namisaki, Kei Moriya, Mitsuteru Kitade, et al.Pageof 179